SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Attovia Therapeutics, Inc. (NASDAQ:ATTO)

US · Delayed Price · Currency is USD
22.79+0.26 (+1.15%)
 
Market Cap980.65M+4.1%
Revenue (ttm)450.00K
Net Income-39.34M
EPS-0.93
Shares Out43.03M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume175,769
Open22.43
Previous Close22.53
Day's Range22.00 - 24.01
52-Week Range16.15 - 28.00
Betan/a
Analystsn/a
Price Target45.33(+98.90%)
Earnings Daten/a

About ATTO

A clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases using its ATTOBODY biologics platform. The company's lead candidate, ATTO-1310, targets interleukin-31 (IL-31), known as the 'itch cytokine,' for the treatment of chronic pruritic diseases including atopic dermatitis. Its pipeline also includes multi-specific candidates for other inflammatory diseases.

Address
1091 Industrial Rd, Ste 310, San Carlos, CA, 94070, US
Market Cap
981 million
Employees
44
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$1.94M
Bought
$61.08M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+1.15%
5 Days
-6.75%
1 Month
+22.20%
6 Months
+4.06%
1 Year
+4.06%

$ATTO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ATTO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ATTO's directors and management

Net Shares Purchased by Insiders−4M−2M02025Q32025Q42026Q12026Q22026Q3

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ATTO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New ATTO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ATTO from public contracts

Source: USAspending.gov

ATTO Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for ATTO is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from ATTO’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
9
Sells
10
Buy Value
$61.08M
Distinct Buyers
5

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.